Neutrophil-to-lymphocyte ratio: A disease severity biomarker in stable chronic obstructive pulmonary disease?
文献摘要
Background The neutrophil-to-lymphocyte ratio (NLR) is a biomarker of systemic inflammation that has been investigated in different chronic diseases. However, its role as biomarker of severity in patients with stable chronic obstructive pulmonary disease (COPD), and particularly its association with cardiovascular risk, remains unclear. This retrospective study aimed to evaluate whether a higher NLR (HNLR) is associated with worse disease control and increased cardiovascular risk compared to a lower NLR (LNLR) in stable COPD. Methods Data from inpatients admitted to a pulmonary rehabilitation center between 2021 and 2024 were analyzed. Patients were divided in two groups (HNLR ≥ 2.26 and LNLR Results A total of 247 patients were included. The HNLR group included a significantly (p Conclusion Our data suggest that NLR used together with other clinical and functional parameters could represent a useful biomarker in stable COPD, associated with increased disease severity and higher estimated 10-year cardiovascular risk.